Takeda Pharmaceutical's ENTYVIO sales value FY 2018-2022
In fiscal year 2022, the sales value of ENTYVIO produced by Takeda Pharmaceutical Co., Ltd. accounted for approximately 702.7 billion Japanese yen, marking the highest sales value over a five-year period. In contrast, the sales value of ENTYVIO amounted to 269.2 billion yen in fiscal year 2018. Throughout the period, the sales value demonstrated a steady uprising trend.